Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[The dynamin-2-gene related centronuclear myopathy].

Medecine sciences : M/S - 1 Nov 2023

Bitoun Marc

Abstract excerpt

Autosomal dominant centronuclear myopathy (AD-CNM) is a rare congenital myopathy characterized by muscle weakness and centrally located nuclei in muscle fibers in the absence of any regeneration. AD-CNM is due to mutations in the DNM2 gene encoding dynamin 2 (DNM2), a large GTPase involved in intracellular membrane trafficking and a regulator of actin and microtubule cytoskeletons. DNM2 mutations are associated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dynamin II
Share to Infant, Newborn
Share to Muscle Fibers, Skeletal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Muscle, Skeletal

Share to Mutation

Share to Myopathies, Structural, Congenital

Source

Identifiers

PMID: 37975763
DOI: 10.1051/medsci/2023130

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[The dynamin-2-gene related centronuclear myopathy].PMID 37975763Read ↗

A novel mutation in the DNM2 gene impairs dynamin 2 localization in skeletal muscle of a patient with late onset centronuclear myopathy.Semantic proximity Read ↗

Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy.Semantic proximity Read ↗

Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations.Semantic proximity Read ↗

Reducing dynamin 2 (DNM2) rescues DNM2 -related dominant centronuclear myopathySemantic proximity Read ↗

DNM2 levels normalization improves muscle phenotypes of a novel mouse model for moderate centronuclear myopathySemantic proximity Read ↗

Physiological impact and disease reversion for the severe form of centronuclear myopathy linked to dynamin.Semantic proximity Read ↗

A new centronuclear myopathy phenotype due to a novel dynamin 2 mutation.Semantic proximity Read ↗

A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice.Semantic proximity Read ↗

Centronuclear myopathies under attack: A plethora of therapeutic targetsSemantic proximity Read ↗

Mutations in dynamin 2 cause dominant centronuclear myopathy.Semantic proximity Read ↗

Clinical, pathological and genetic characteristics of autosomal dominant inherited dynamin 2 centronuclear myopathy.Semantic proximity Read ↗

Reducing dynamin 2 expression rescues X-linked centronuclear myopathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.